Aspen Aerogels (NYSE:ASPN) Price Target Lowered to $22.00 at B. Riley

Aspen Aerogels (NYSE:ASPN - Free Report) had its price target trimmed by B. Riley from $35.00 to $22.00 in a research report sent to investors on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the construction company's stock. B. Riley also issued estimates for Aspen Aerogels' Q1 2025 earnings at ($0.08) EPS, Q2 2025 earnings at $0.02 EPS, Q3 2025 earnings at $0.13 EPS, Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.22 EPS, FY2026 earnings at $0.75 EPS and FY2027 earnings at $1.30 EPS.

A number of other equities analysts have also commented on the company. Barclays cut their price target on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a report on Wednesday. Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Roth Mkm lowered their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. Finally, Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $22.44.

Aspen Aerogels Stock Performance

Shares of ASPN stock traded down $0.12 during trading on Wednesday, hitting $8.04. The company's stock had a trading volume of 2,201,033 shares, compared to its average volume of 2,133,322. The company has a market cap of $659.27 million, a PE ratio of 50.22 and a beta of 2.14. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The business has a fifty day moving average of $11.75 and a 200-day moving average of $18.15. Aspen Aerogels has a 52 week low of $7.96 and a 52 week high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. As a group, research analysts anticipate that Aspen Aerogels will post 0.22 earnings per share for the current year.

Institutional Investors Weigh In On Aspen Aerogels

A number of large investors have recently added to or reduced their stakes in the company. Abbot Financial Management Inc. raised its position in Aspen Aerogels by 3.9% during the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company's stock valued at $359,000 after purchasing an additional 1,146 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of Aspen Aerogels by 5.3% in the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company's stock worth $815,000 after buying an additional 1,483 shares during the period. Invesco Ltd. increased its holdings in shares of Aspen Aerogels by 3.5% in the fourth quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock worth $604,000 after buying an additional 1,724 shares during the period. Greenwood Capital Associates LLC increased its holdings in shares of Aspen Aerogels by 5.0% in the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock worth $439,000 after buying an additional 1,749 shares during the period. Finally, MetLife Investment Management LLC increased its holdings in shares of Aspen Aerogels by 6.3% in the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock worth $425,000 after buying an additional 2,118 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.